Iovance Biotherapeutics, Inc.
IOVABiotechnology
$9.56−35.45%As of Oct 29vs prior close
- Market cap
- $4.3B
- P/E (TTM)
- –
- From 52W high
- −35.67%
- EPS (LTM)
- -$0.70
- Revenue (LTM)
- $325M
- Net margin
- -89.09%
- Dividend yield
- 0.00%
Nomior Score
64
Emerging BreakoutSpeculativeTop 19% of the scored universe
Growth70
Quality45
Value52
Momentum100
Resilience26
Growth
$325Mrevenue, LTM
YE16 $0LTM $325M
Connections
Revenue to profitQ2 YE26
The operating loss was 52% of revenue, narrower by 138 pts on a year.
Who owns it
2funds